| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |